38万片杜冷丁从公立医院流向毒品市场，院长被判死缓

Core Viewpoint - The Supreme People's Court highlighted the increasing issue of the abuse of narcotic and psychotropic drugs, particularly the illegal diversion of medical drugs into the drug market, as exemplified by the case of a hospital director involved in the illegal sale of a controlled substance [1][2][3] Group 1: Case Details - The defendant, Su, served as the director of a public hospital and exploited his position to illegally acquire and sell 536,180 tablets of a narcotic drug, with profits exceeding 1 million yuan [1][2] - Su sold approximately 380,000 tablets at prices ranging from 1.5 to 7 yuan each, primarily to unemployed individuals, facilitating the drug's entry into the illegal market [1][2] - The court found Su's actions constituted drug trafficking, given his awareness of the potential for abuse and the significant social harm caused by his actions [2][3] Group 2: Legal Consequences - Su was sentenced to death with a two-year reprieve, stripped of political rights for life, and ordered to forfeit all personal property due to the severity of his crimes [2][3] - The case underscores the serious legal repercussions for individuals in positions of authority who engage in illegal drug distribution, particularly in the context of increasing government crackdowns on drug-related crimes [2][3] Group 3: Industry Implications - The case reflects a broader trend where traditional drugs are becoming harder to obtain, leading some drug users to seek out medical narcotics as substitutes, raising concerns about the integrity of the healthcare system [2][3] - The dual nature of substances like fentanyl, which can be both a medication and a drug, poses significant risks to public health when diverted into illegal markets [3]